(A) Neonatal testing conducted pursuant to Section 44-37-30 must include testing for the following:
(1) Krabbe disease;
(2) Pompe disease; and
(3) Hurler syndrome.
(B) The department shall require additional lysosomal storage disorders to be tested upon the recommendations of the Newborn Screening Advisory Committee and in accordance with Section 44-37-30 pursuant to a duly promulgated regulation as testing for such disorders becomes available.